Discover · financialpost.com

Teva Announces New Olanzapine LAI (TEV-‘749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults

financialpost.com

More from financialpost.com

MISSION SUCCESS: Rocket Lab Launches 96th Electron Missionfinancialpost.comCollective Metals Announces Management Changesfinancialpost.comLiberty Gold Files Feasibility Study Technical Report for the Black Pine Project in Idaho, USAfinancialpost.comAjax library workers reject two-tier contract: ‘We need a fair deal for everyone’financialpost.comGreenland Mines Applauds Historic U.S.-Denmark-Greenland Security Agreement, Reinforcing Greenland’s Strategic Importance to the United Statesfinancialpost.comOttawa’s ‘mega deduction’ tax write-off could boost these TSX stocks, analysts sayfinancialpost.com

Also in Discover

  1. Has Sony's Stopping Physical Games Inspired Anyone Else to Go Buy a Switch 2?resetera.com
  2. So who will be playable in Insomniac's X-Men game? (some Wolverine spoilers in the thread)resetera.com
  3. Pragmata has sold over 2.5 millionresetera.com
  4. FootyEra 26/27 Season |OT| Pay to Postresetera.com
  5. Wash your Ass.resetera.com
  6. College Football 2026 season |OT|resetera.com